Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angiogenic imaging study of sunitinib added to FOLFIRI in metastatic colorectal cancer with liver metastases
2008-001515-37Phase 2Completed
- Sponsor
- Central European Society for Anticancer Drug Research
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of sunitinib in colorectal cancer (CRC), sponsored by Central European Society for Anticancer Drug Research. Primary endpoints: Change in tumor vessel permeability and blood flow by DCE-MRI and Change in tumor vessel permeability and blood flow by DCE-ultrasound imaging. Started Nov 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2008-001515-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001515-37.